Department of Clinical Neuroscience, Karolinska Institutet, Karolinska Hospital R5:02, Stockholm 17176, Sweden
Department of Neurology, University Hospital Vienna, Vienna, Austria
Nuclear Medicine Division, Université Catholique de Louvain, Mont-Godinne Medical Center, Mont-Godinne, Belgium
Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Clinical Neurophysiology Unit, San Martino Hospital, University of Genova, Genova, Italy
Nuclear Medicine, Université de Nice Sophia Antipolis, University Hospital, Nice, France
Division of Nuclear Medicine, Ludwig-Maximillians University, Munich, Germany
References: Bartenstein, P., Asenbaum, S., Catafau, A., European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG (2002) Eur J Nucl Med Mol Imaging, 29, pp. BP43-BP48. , 1:STN:280:DC%2BD38nntl2ruw%3D%3D 1243649
Kuwert, T., Bartenstein, P., Grünwald, F., Clinical value of positron emission tomography in neuromedicine. Position paper on results of an interdisciplinary consensus conference (1989) Nervenarzt, 69, pp. 1045-1160. , 10.1007/s001150050382
Asenbaum, S., (2001) Guideline for the Use of FDG PET in Neurology and Psychiatry, , http://www.ogn.at, Austrian Society of Nuclear Medicine
Schelbert, H.R., Hoh, C.K., Royal, H.D., Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine (1998) J Nucl Med, 39, pp. 1302-1305. , 1:STN:280:DyaK1czjt1Skug%3D%3D 9669415
Ethical clinical practice of functional brain imaging (1996) J Nucl Med, 37, pp. 1256-1259. , Society of Nuclear Medicine Brain Imaging Council
Setani, K., Schreckenberger, M., Sabri, O., Comparison of different methods for attenuation correction in brain PET: Effect on the calculation of the metabolic rate of glucose (2000) Nuklearmedizin, 39, pp. 50-55. , 1:STN:280:DC%2BD3c3jtVOhsA%3D%3D 10768170
Herholz, K., Salmon, E., Perani, D., Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET (2002) Neuroimage, 17, pp. 302-316. , 10.1006/nimg.2002.1208 1:STN:280:DC%2BD38jhvFOhsQ%3D%3D 12482085
Herholz, K., Carter, S.F., Jones, M., Positron emission tomography imaging in dementia (2007) British Journal of Radiology, 80 (SPEC. ISS. 2), pp. S160-S167. , DOI 10.1259/bjr/97295129
Mosconi, L., Tsui, W.H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E.M., De Leon, M.J., Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias (2008) Journal of Nuclear Medicine, 49 (3), pp. 390-398. , http://jnm.snmjournals.org/cgi/reprint/49/3/390, DOI 10.2967/jnumed.107.045385
Dubois, B., Feldman, H.H., Jacova, C., DeKosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Scheltens, P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria (2007) Lancet Neurology, 6 (8), pp. 734-746. , DOI 10.1016/S1474-4422(07)70178-3, PII S1474442207701783
Kaschten, B., Stevenaert, A., Sadzot, B., Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine (1998) J Nucl Med, 39, pp. 778-785. , 1:CAS:528:DyaK1cXjsVShtbY%3D 9591574
Henry, T.R., Votaw, J.R., The role of positron emission tomography with [18F] fluorodeoxyglucose in the evaluation of the epilepsies (2004) Neuroimaging Clinics of North America, 14 (3), pp. 517-535. , DOI 10.1016/j.nic.2004.04.011, PII S1052514904000462
Van Paesschen, W., Dupont, P., Sunaert, S., Goffin, K., Van Laere, K., The use of SPECT and PET in routine clinical practice in epilepsy (2007) Current Opinion in Neurology, 20 (2), pp. 194-202. , DOI 10.1097/WCO.0b013e328042baf6, PII 0001905220070400000013
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M.F., Feigin, A.S., Eidelberg, D., FDG PET in the differential diagnosis of parkinsonian disorders (2005) NeuroImage, 26 (3), pp. 912-921. , DOI 10.1016/j.neuroimage.2005.03.012, PII S1053811905001527
Hasselbalch, S.G., Knudsen, G.M., Videbaek, C., Pinborg, L.H., Schmidt, J.F., Holm, S., Paulson, O.B., No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans (1999) Diabetes, 48 (10), pp. 1915-1921. , DOI 10.2337/diabetes.48.10.1915
Cranston, I., Marsden, P., Matyka, K., Regional differences in cerebral blood flow and glucose utilization in diabetic man: The effect of insulin (1998) J Cereb Blood Flow Metab, 18, pp. 130-140. , 10.1097/00004647-199802000-00002 1:CAS:528:DyaK1cXhtFWjsrw%3D 9469154
Spanaki, M.V., Siegel, H., Kopylev, L., The effect of vigabatrin (gamma-vinyl GabA) on cerebral blood flow and metabolism (1999) Neurology, 53, pp. 1518-1522. , 1:CAS:528:DyaK1MXntlWhu7c%3D 10534261
Berding, G., Odin, P., Brooks, D.J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., Knapp, W.H., Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET (2001) Movement Disorders, 16 (6), pp. 1014-1022. , DOI 10.1002/mds.1212
Felgin, A., Fukuda, M., Dhawan, V., Metabolic correlates of levodopa response in Parkinsońs disease (2001) Neurology, 57, pp. 2083-2088
Ruotsalainen, U., Suhonen-Polvi, H., Eronen, E., Estimated radiation dose to the newborn in FDG-PET studies (1996) J Nucl Med, 37, pp. 387-393. , 1:CAS:528:DyaK28XhvVals7s%3D 8667081
Wu, T.-H., Huang, Y.-H., Lee, J.J.S., Wang, S.-Y., Wang, S.-C., Su, C.-T., Chen, L.-K., Chu, T.-C., Radiation exposure during transmission measurements: Comparison between CT- and germanium-based techniques with a current PET scanner (2004) European Journal of Nuclear Medicine and Molecular Imaging, 31 (1), pp. 38-43. , DOI 10.1007/s00259-003-1327-6
Chen, W.P., Matsunari, I., Noda, A., Rapid scanning protocol for brain (18)F-FDG PET: A validation study (2005) J Nucl Med, 46, pp. 1633-1641. , 16204713
Lucignani, G., Schmidt, K.C., Moresco, R.M., Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissue: Theoretical considerations and practical procedure (1993) J Nucl Med, 34, pp. 360-369. , 1:CAS:528:DyaK3sXit12gtrw%3D 8441024
Phelps, M.E., PET: The merging of biology and imaging into molecular imaging (2000) J Nucl Med, 41, pp. 661-681. , 1:STN:280:DC%2BD3c3ivFSmtw%3D%3D 10768568
Henry, T.R., Engel Jr, J., Mazziotta, J.C., Clinical evaluation of interictal fluorine-18-fluordeoxyglucose PET in partial epilepsy (1993) J Nucl Med, 34, pp. 1892-1998. , 1:STN:280:DyaK2c%2FksF2nug%3D%3D 8229230
Herholz, K., Pietrzyk, U., Karbe, H., Wurker, M., Wienhard, K., Heiss, W.-D., Individual metabolic anatomy of repeating words demonstrated by MRI-guided positron emission tomography (1994) Neuroscience Letters, 182 (1), pp. 47-50. , DOI 10.1016/0304-3940(94)90202-X
Minoshima, S., Koeppe, R.A., Mintun, M.A., Automated detection of the intercommissural line for stereotactic localization of functional brain images (1993) J Nucl Med, 34, pp. 322-329. , 1:STN:280:DyaK3s7lsFOiuw%3D%3D 8429356
Graham, M.M., Muzi, M., Spence, A.M., The FDG lumped constant in normal human brain (2002) J Nucl Med, 43, pp. 1157-1166. , 12215553
Minoshima, S., Frey, K.A., Koeppe, R.A., A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET (1995) J Nucl Med, 36, pp. 1238-1248. , 1:STN:280:DyaK2MzhtFSgtQ%3D%3D 7790950
Frackowiak, R.S.J., Friston, K.J., Frith, C.D., Dolan, R.J., Mazziotta, J.C., (1997) Human Brain Function, , Academic Press London
Drzezga, A., Arnold, S., Minoshima, S., F-18 FDG-PET studies in patients with extratemporal and temporal epilepsy: Evaluation of an observer-independent analysis (1999) J Nucl Med, 40, pp. 737-746. , 1:STN:280:DyaK1M3ltFClsA%3D%3D 10319744
Cook, G.J.R., Maisey, M.N., Fogelman, I., Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine (1999) European Journal of Nuclear Medicine, 26 (10), pp. 1363-1378. , DOI 10.1007/s002590050597
Schelbert, H. R., Hoh, C. K., Royal, H. D., Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine (1998) J Nucl Med, 39, pp. 1302-1305. , 1: STN: 280: DyaK1czjt1Skug%3D%3D 9669415
Henry, T. R., Votaw, J. R., The role of positron emission tomography with [18F] fluorodeoxyglucose in the evaluation of the epilepsies (2004) Neuroimaging Clinics of North America, 14 (3), pp. 517-535. , DOI 10. 1016/j. nic. 2004. 04. 011, PII S1052514904000462
Hasselbalch, S. G., Knudsen, G. M., Videbaek, C., Pinborg, L. H., Schmidt, J. F., Holm, S., Paulson, O. B., No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans (1999) Diabetes, 48 (10), pp. 1915-1921. , DOI 10. 2337/diabetes. 48. 10. 1915
Spanaki, M. V., Siegel, H., Kopylev, L., The effect of vigabatrin (gamma-vinyl GabA) on cerebral blood flow and metabolism (1999) Neurology, 53, pp. 1518-1522. , 1: CAS: 528: DyaK1MXntlWhu7c%3D 10534261
Wu, T. -H., Huang, Y. -H., Lee, J. J. S., Wang, S. -Y., Wang, S. -C., Su, C. -T., Chen, L. -K., Chu, T. -C., Radiation exposure during transmission measurements: Comparison between CT- and germanium-based techniques with a current PET scanner (2004) European Journal of Nuclear Medicine and Molecular Imaging, 31 (1), pp. 38-43. , DOI 10. 1007/s00259-003-1327-6
Chen, W. P., Matsunari, I., Noda, A., Rapid scanning protocol for brain (18) F-FDG PET: A validation study (2005) J Nucl Med, 46, pp. 1633-1641. , 16204713
Phelps, M. E., PET: The merging of biology and imaging into molecular imaging (2000) J Nucl Med, 41, pp. 661-681. , 1: STN: 280: DC%2BD3c3ivFSmtw%3D%3D 10768568
Henry, T. R., Engel Jr, J., Mazziotta, J. C., Clinical evaluation of interictal fluorine-18-fluordeoxyglucose PET in partial epilepsy (1993) J Nucl Med, 34, pp. 1892-1998. , 1: STN: 280: DyaK2c%2FksF2nug%3D%3D 8229230
Graham, M. M., Muzi, M., Spence, A. M., The FDG lumped constant in normal human brain (2002) J Nucl Med, 43, pp. 1157-1166. , 12215553
Frackowiak, R. S. J., Friston, K. J., Frith, C. D., Dolan, R. J., Mazziotta, J. C., (1997) Human Brain Function, , Academic Press London
Cook, G. J. R., Maisey, M. N., Fogelman, I., Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine (1999) European Journal of Nuclear Medicine, 26 (10), pp. 1363-1378. , DOI 10. 1007/s002590050597
EANM procedure guidelines for PET brain imaging using [18F]FDG, version
Ciccarelli M, Sorriento D, Coscioni E, Iaccarino G, Santulli G * Adrenergic Receptors(261 views) Endocrinol Of The Heart In Health And Dis (ISSN: 9780-1280311249780128031117), 2016; N/D: 285-315. Impact Factor:0 ViewExport to BibTeXExport to EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(295 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(761 views) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 ViewExport to BibTeXExport to EndNote